02/14/2025
8:01 AM | Lynx1 Capital Management LP (Filed by)
Passage Bio (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
3:21 PM | Borthwick Kathleen (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
4:17 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
5:09 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:05 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:34 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:31 PM | ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
| Form SCHEDULE 13D/A | |
12/11/2024
4:32 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
6:07 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:11 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for PASG and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Passage Bio and its competitors with MarketBeat's FREE daily newsletter. |
11/14/2024
4:21 PM | Erste Asset Management GmbH (Filed by)
Passage Bio (Subject)
| Form SCHEDULE 13G/A | |
11/13/2024
6:15 AM | Passage Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
3:41 PM | Cale Edgar B. (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
3:51 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
5:38 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:36 PM | ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
7:38 PM | ORBIMED CAPITAL LLC (Reporting)
Passage Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
3:15 PM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:06 PM | Passage Bio (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
08/09/2024
4:11 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
Passage Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/09/2024
4:15 PM | Lynx1 Capital Management LP (Filed by)
Passage Bio (Subject)
| Form SC 13G/A | |
08/08/2024
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:15 AM | Passage Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2024
6:01 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
3:35 PM | Passage Bio (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
05/23/2024
4:43 PM | Countouriotis Athena (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
3:51 PM | Passage Bio (Issuer)
Porter Derrell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
3:52 PM | Passage Bio (Issuer)
Sondhi Dolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
3:53 PM | Islam Saqib (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
3:55 PM | Kapadia Sandip (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
3:56 PM | GOWEN MAXINE (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
7:15 AM | Passage Bio (Filer)
| Form 424B3 | |
05/14/2024
6:01 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
6:15 AM | Passage Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/16/2024
11:15 PM | Passage Bio (Filer)
| Form EFFECT | |
This Crypto Is Set to Explode in February (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
04/12/2024
4:35 PM | ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
| Form SC 13D/A | |
04/09/2024
8:35 AM | Passage Bio (Filer)
| Form DEFA14A | |
04/09/2024
5:00 AM | Passage Bio (Filer)
| Form ARS | |
04/09/2024
5:02 AM | Passage Bio (Filer)
| Form DEF 14A | |
03/29/2024
3:15 PM | Lynx1 Capital Management LP (Filed by)
Passage Bio (Subject)
| Form SC 13G | |
03/04/2024
6:15 AM | Passage Bio (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
6:02 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:06 PM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
